Regeneron/Sanofi — Drug Prices & Medicare Spending
Regeneron/Sanofi manufactures 4 drugs tracked by Medicare Part D with total spending of $6.3B.
4
Drugs Tracked
$6.3B
Medicare Spending
$2,146.22
Avg Cost/Claim
75%
Have Generics
Regeneron/Sanofi Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Dupixent | Dupilumab | $2,819.00 | No |
| 2 | Praluent | Alirocumab | $706.00 | Yes |
| 3 | Libtayo | Cemiplimab | $14,125.00 | Yes |
| 4 | Kevzara | Sarilumab | $4,012.00 | Yes |
Frequently Asked Questions
Regeneron/Sanofi manufactures 4 drugs tracked by Medicare Part D, with total annual spending of $6.3B.
Libtayo (Cemiplimab) is the most expensive at $14,125.00 per claim.
3 of 4 Regeneron/Sanofi drugs (75%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.